Early Access — free while we kick the tires
Never miss a filing from Gilmartin Kathleen A
Watch this insider and we'll alert you the moment they file — at any company.
Activity
November 2025
Director Kathleen A Gilmartin bought 4,000 shares of USPH at $69.00 on 2025-11-20; stock down 28.4% from 52-week high.
Director Kathleen A Gilmartin purchased 4,000 shares at $69.00, increasing her holdings by 19.2% to 24,786 shares. This marks her third open-market purchase at USPH, and her prior two purchases at this ticker demonstrated favorable 90-day outcomes: +15.4% (2024-09-03 buy) and +13.9% (2023-11-10 buy). The current transaction occurs as the stock trades at $71.50, down 28.4% from its 52-week high of $99.91 and down 23.2% over the prior 30 days, while the company maintains solid fundamentals with $197.1M in latest quarterly revenue, $13.1M in net income, and 11.0% annual revenue growth. Her cross-ticker track record shows a 100% win rate on 90-day returns across 2 prior buys (avg +14.7%), suggesting consistent ability to identify value entry points, though this new position's timing relative to near-term technicals and sentiment requires monitoring against the company's earnings trajectory.
September 2024
Director Kathleen A. Gilmartin purchases 2,000 shares of USPH at $86.09; stock down 23.8% from 52-week high despite prior well-timed buy pattern.
Director Kathleen A. Gilmartin purchased 2,000 shares at $86.09 on 2024-09-03, increasing her holdings by 11.8% to 18,904 shares. This represents her second open-market purchase at USPH; her prior buy in November 2023 at this ticker delivered a 13.9% return over 90 days. However, the current purchase occurs against a backdrop of significant recent weakness: the stock has declined 9.2% over the prior 30 days and 13.2% over 90 days, placing it 23.8% below its 52-week high of $112.87. While her cross-ticker track record shows a 100% win rate with an average 90-day return of +13.9%, and her same-ticker history demonstrates well-timed buying (1 of 1 prior buys were well-timed at the 90-day mark), the company's elevated P/E of 50.88 against modest net income of $7.5M on revenue of $167.2M reflects a valuation structure that warrants observation of near-term price action relative to the insider's purchase thesis.